Cargando…

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy

Detalles Bibliográficos
Autores principales:	Mensah, Afua Adjeiwaa, Mondello, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572502/ https://www.ncbi.nlm.nih.gov/pubmed/36233702 http://dx.doi.org/10.3390/jcm11195834

Ejemplares similares

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
por: Priebe, Valdemar, et al.
Publicado: (2020)

Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma
por: Minderman, Marthe, et al.
Publicado: (2020)

Harnessing RNAi nanomedicine for precision therapy
por: Peer, Dan
Publicado: (2014)

Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
por: Napoli, Sara, et al.
Publicado: (2021)

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Sartori, Giulio, et al.
Publicado: (2021)

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014)

Insights into the tumor microenvironment of B cell lymphoma
por: Ng, Wern Lynn, et al.
Publicado: (2022)

Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Fingerprint
por: Gullo, Giuseppe, et al.
Publicado: (2023)

Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell Lymphoma
por: Mondello, Patrizia, et al.
Publicado: (2022)

Again in Harness
Publicado: (1891)

Harnessing Oxidative Stress as an Innovative Target for Cancer Therapy
por: Postovit, Lynne, et al.
Publicado: (2018)

Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022)

Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphoma
por: Patrone, Christina Chung, et al.
Publicado: (2019)

Intensified therapy in diffuse large B-cell lymphoma
por: Novo, Mattia, et al.
Publicado: (2017)

Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease
por: Mondello, Patrizia, et al.
Publicado: (2014)

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
por: Tarantelli, Chiara, et al.
Publicado: (2018)

Accelerated Wound Healing: Harnessing the Power of Platelets, Biomaterials, Stem Cells and Gene Therapy
por: Khunger, Niti
Publicado: (2017)

Harnessing the peace dividends of health
por: Al Mandhari, Ahmed, et al.
Publicado: (2021)

Harnessing Solute Carrier Transporters for Precision Oncology
por: Nyquist, Michael D., et al.
Publicado: (2017)

Fatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell Lymphoma
por: Pitini, Vincenzo, et al.
Publicado: (2012)

Harnessing the immune system in the treatment of cutaneous T cell lymphomas
por: Fay, Christopher J., et al.
Publicado: (2023)

Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma
por: Visweshwar, Nathan, et al.
Publicado: (2023)

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
por: Paduano, Francesco, et al.
Publicado: (2018)

Harnessing the vasculo-protective potential of microglia
por: Halder, Sebok K., et al.
Publicado: (2023)

Unique Raman Spectroscopic Fingerprints of B-Cell Non-Hodgkin Lymphoma: Implications for Diagnosis, Prognosis and New Therapies
por: Shiramizu, B, et al.
Publicado: (2018)

Aggressive B-Cell Lymphomas
por: Naresh, Kikkeri N., et al.
Publicado: (2012)

Harnessing Protein-Ligand Interaction Fingerprints to Predict New Scaffolds of RIPK1 Inhibitors
por: Aniceto, Natália, et al.
Publicado: (2022)

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma
por: Quintás-Cardama, Alfonso
Publicado: (2018)

Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
por: Chen, Huan, et al.
Publicado: (2021)

A tribute to DNA fingerprinting
por: Kayser, Manfred, et al.
Publicado: (2013)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Raman Fingerprints of Atomically Precise Graphene Nanoribbons
por: Verzhbitskiy, Ivan A., et al.
Publicado: (2016)

Harnessing electronic data to inform health decisions
por: Sarkar, Indra Neil
Publicado: (2019)

Harness Technology—Enhance Health Care Experiences
por: Cooley, Laura
Publicado: (2020)

Harnessing the power of behavioural science to improve health
por: Altieri, Elena, et al.
Publicado: (2021)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Product/Process Fingerprint in Micro Manufacturing
por: Tosello, Guido
Publicado: (2019)

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
por: Rampotas, Alexandros, et al.
Publicado: (2021)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Ikaros as a downstream mediator of BCR blockade therapy in B-cell non-Hodgkin lymphoma
por: Ribeiro, Marcelo Lima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rrcfpa9odgj9gog6rhu8r7gfaa